Carolyn Ng Ph.D Overview
- Company
- Bicara Therapeut...
- Primary Position
-
Board Member
- Primary Industry
-
Healthcare
- Active Board Seats
-
3
- Med. Deal Size
-
- Med. Valuation
-
Carolyn Ng Ph.D General Information
Biography
Dr. Carolyn Ng serves as a Partner and Managing Director at TPG. Dr. Ng serves as a Board Member at MBrace Therapeutics and Adcendo. She serves as Board Member at Bicara Therapeutics. Prior to joining TPG in 2021, she was a Managing Director at Vertex Ventures HC, a global healthcare and life sciences venture fund, where she co-headed the investment team and led deals across different therapeutic areas in life sciences. She has served on the board of directors for several promising life sciences companies including, Bicycle Therapeutics PLC (NASDAQ: BCYC), Boundless Bio, Obsidian Therapeutics, 28-7 Therapeutics, and a board observer to Visterra (acquired by Otsuka Pharmaceutical). She is also a mentor to the Women in Bio Boardroom Ready Program. She holds a Ph.D. in Cancer Molecular Biology from the National University of Singapore, where she was the recipient of the prestigious NGS, Integrative Sciences and Technology, Ph.D. scholarship.
Contact Information
Address
- 116 Huntington Avenue
- Suite 703
- Boston, MA 02116
- United States
Carolyn Ng Ph.D Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| TPG | Investor | Partner & Managing Director | Fort Worth, TX | PE/Buyout |
Carolyn Ng Ph.D Board Seats (3)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Adcendo | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Frederiksberg, Denmark | |
| Bicara Therapeutics | Drug Discovery | Publicly Held | Formerly VC-backed | Boston, MA | |
| MBrace Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | San Diego, CA |
Carolyn Ng Ph.D Lead Partner on Deals (10)
Carolyn Ng Ph.D has been the lead partner on 10 deals. Their latest deal was with Adcendo, a drug discovery company. The deal was made for on 06-Nov-2024.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Adcendo | 06-Nov-2024 | Later Stage VC (Series B) | Completed | Drug Discovery | Frederiksberg, Denmark | |
| Bicara Therapeutics | 06-Dec-2023 | Completed | Drug Discovery | Boston, MA | ||
| MBrace Therapeutics | 21-Nov-2023 | Completed | Drug Discovery | San Diego, CA | ||
| Redona Therapeutics | 16-Jun-2022 | Completed | Drug Discovery | Watertown, MA | ||
| Obsidian Therapeutics | 09-Sep-2021 | Completed | Drug Discovery | Cambridge, MA | ||
| Boundless Bio | 28-Apr-2021 | Completed | Drug Discovery | San Diego, CA | ||
| Epirium Bio | 19-Jun-2020 | Completed | Drug Discovery | San Diego, CA | ||
| ElevateBio | 12-Mar-2020 | Completed | Biotechnology | Waltham, MA | ||
| Boundless Bio | 19-Sep-2019 | Early Stage VC (Series A) | Completed | Drug Discovery | San Diego, CA | |
| Obsidian Therapeutics | 06-Dec-2017 | Early Stage VC (Series A) | Completed | Drug Discovery | Cambridge, MA |
Carolyn Ng Ph.D Network (240)
Board Members (121)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Ohad Hammer | Adcendo | Pontifax Venture Capital | Frederiksberg, Denmark | |
| George Schreiner Ph.D | Epirium Bio | Epirium Bio | San Diego, CA | |
| Epirium Bio | Longitude Capital | San Diego, CA | ||
| Boundless Bio | Boundless Bio | San Diego, CA | ||
| Bicycle Therapeutics | Self | Cambridge, United Kingdom |
Portfolio Executives (89)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Carmel Lynch Ph.D | Adcendo | Chief Development Officer | 06-Nov-2024 | Frederiksberg, Denmark |
| Henrik Stage | Adcendo | Co-Founder | 06-Nov-2024 | Frederiksberg, Denmark |
| Adcendo | Chief Technology Officer | 06-Nov-2024 | Frederiksberg, Denmark | |
| Adcendo | VP Operations, General Manager & Co-founder | 06-Nov-2024 | Frederiksberg, Denmark | |
| Adcendo | ESG & Finance Director | 06-Nov-2024 | Frederiksberg, Denmark |
Fund Team Members (30)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Edward Beckley | TPG | The Rise Fund | Fort Worth, TX |
| Edward Beckley | The Rise Fund | The Rise Fund | San Francisco, CA |
| TPG | Fort Worth, TX | ||
| The Rise Fund | San Francisco, CA | ||
| TPG | Fort Worth, TX |
Carolyn Ng Ph.D Affiliated Funds (2)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| TPG Life Sciences Innovations Fund | TPG | Venture - General | Closed | 2023 | ||||
| The Rise Fund | TPG | Growth/Expansion | Closed | 2017 |
Carolyn Ng Ph.D FAQs
-
Who is Carolyn Ng Ph.D?
Dr. Carolyn Ng serves as a Partner and Managing Director at TPG.
-
How much does Carolyn Ng Ph.D typically invest?
Carolyn Ng Ph.D's median deal size is .
-
What is Carolyn Ng Ph.D’s main position?
Carolyn Ng Ph.D’s primary position is Board Member.
-
What are the contact details for Carolyn Ng Ph.D?
Carolyn Ng Ph.D’s email address is cn and his phone number is +1 (617) .
-
How many active board seats does Carolyn Ng Ph.D hold?
Carolyn Ng Ph.D holds 3 board seats including Adcendo, Bicara Therapeutics, and MBrace Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
